Retinitis Pigmentosa (RP) refers to a group of inherited
diseases that damage the light sensitive rods and cones in the retina. The rods
are affected more than the cones. The rods provide peripheral vision and night
vision. The cones provide colour vision and clear central vision. RP patients initially
have night blindness (nyctalopia) and peripheral vision loss that may subsequently
lean onto central vision loss.
Inheritance
·
Autosomal recessive –
most common type of RP. The chance of having this condition is higher if the
patients are related (eg:cousins).
·
Autosomal dominant - in
this form of RP, only one parent has the gene and is usually affected by the
disease as well. Each child has a 50 percent chance of inheriting this gene and
developing RP.
·
X linked – if the father is affected, all sons will
be unaffected and all daughters will be carriers. If the mother is the carrier,
1 in 2 sons will be
affected and in 2 daughters will be carriers.
Prevalence and Demography
·
Prevalence – RP is considered a rare disorder. It is
generally estimated that the disorder affects roughly 1 in 4000 people.
·
Age – It appears in the childhood and progress slowly, often
resulting in blindness in advanced middle age.
·
Sex – Males are more commonly affected than females in a
ratio of 3:2.
·
Laterality – Disease is
almost invariably bilateral and both eyes are equally affected.
Pathogenesis
RP is an inherited disorder
that results from harmful changes in any one of more than 50 genes. These genes
carry the instructions for making proteins that are needed in cells in the
retina, called photoreceptors. Some of the changes, or mutations with in genes
are so severe that the gene can’t make the required protein, limiting the cells
functions. Other mutations produce a protein that is toxic to the cell. Still
other mutations lead to an abnormal protein in that doesn’t function properly.
In all these cases, the result is damage to the photoreceptors.
Clinical
Features
Typically
RP, in which rods are degenerated early and cones are involved late, is
characterized by following features:
1.
Visual changes –
·
Night blindness-
It is the characteristic and earliest features and may present several years
before the visible changes in the retina appear. It occurs due to degeneration
of the rods.
·
Dark
adaptation- Light threshold of the peripheral retina is increased, though the
process of dark adaptation itself is not affected untill very late.
· Tubular vision, ie) loss of peripheral vision with preservation of central vision occurs in advanced cases.
·
Central
vision is also lost ultimately after many years.
2.
Fundus changes –
· Retinal pigmentary changes- These are typically perivascular (around veins) and jet black spots resembling bone corpuscles in shape. Initially, these changes are found in the equatorial region only and later spread both anteriorly and posteriorly.
Retinal arterioles are narrowed and may become thread- like in late stages.
·
Thinning
and atrophy of retinal pigment epithelium is seen in peripheral retina.
·
Optic
disc becomes pale and waxy in later stages and ultimately consecutive optic atrophy
occurs.
3. Visual field
changes –
·
Annular
or ring shaped scotoma is a typical feature which corresponds to the
degenerated equatorial zone of retina.
Associations of Retinitis
pigmentosa
1. Ocular associations
·
Myopia
·
Primary
open angle glaucoma
·
Microphthalmos
·
Conical
cornea
·
Posterior
subcapsular cataract
2. Systemic
associations
·
Laurence
Moon Biedl syndrome- It is characterized by retinitis pigmentosa, obesity, hypogenitalism,
polydactyly and mental deficiency.
·
Cockayne's
syndrome- It is characterized by retinitis pigmentosa, peripheral neuropathy
and cerebellar ataxia.
·
Usher's
syndrome- It includes retinitis pigmentosa and labyrinthine deafness.
·
Hallgren's
syndrome- It comprises retinitis pigmentosa, vestibulocerebellar ataxia,
congenital deafness and mental deficiency.
Diagnosis
·
Acuity test – measures the accuracy of central vision.
·
Colour vision testing – helps determine the status of cone cells.
·
Visual field test – to determine the extent of vision loss.
·
Dark adaptation – measures how well eyes adjust to change in
lighting.
·
ERG test (electrophysiological test)- records the electrical currents produced by
the retina due to light stimulus.
Electroretinogram
(ERG) is the most critical diagnostic test for RP because it provides an
objective measure of rod and cone function across the retina.
Treatment
There
is no effective treatment for retinitis pigmentosa. There are some general measures
for supportive management.
·
Vitamin
A Palmitate- High doses of this compound may slow RP.
·
Systemic
acetazolamide for associated cystoid macular edema.
·
Sunglasses-
These make eyes less sensitive to light and protect eyes from harmful UV rays
that may spread vision loss.
·
Low
vision aids in the form of 'magnifying glasses' and ' night vision device' may
be of some help.
·
Replacement
of damaged cells or tissues with healthy ones under investigation.
·
Gene
therapy to put healthy genes into the retina under trial.
·
Bionic
Eye System, a visual prothesis designed to restore functional vision to the
blind suffering from RP.
·
Rehabilitation
of the patient should be earned out as per his socioeconomic background.
·
Prophylaxis-
Genetic counselling for no consanguineous marriages may help to reduce the
incidence of disease.
Dr. Devin Prahbakar MS, FRCS
www.DivyaPrabha.in